Novartis says on track to deliver US vaccine order

Oct 29, 2009

(AP) -- Swiss drugmaker Novartis AG said Thursday it is on track to meet its U.S. government order for swine flu vaccine, seeking to calm fears in recent weeks that shipments and vaccination programs may be delayed.

The Basel-based company said it already has delivered more than 7.5 million doses of vaccine for the A(H1N1) flu that the World Health Organization vaccines declared a in June.

Novartis said it expects to send 25-30 million doses to the United States by the end of November.

"If you look at the U.S. market, there's been a lot of confusion around about how much was to be delivered by when," said spokesman Eric Althoff. "In fact, we're exactly where we told the government we would be."

U.S. authorities said earlier this month they had received only about 23 million of the predicted 45 million vaccine doses from Novartis and other vaccine makers by mid-October. The delay has caused many U.S. states to postpone mass vaccinations, and worried patients have bombarded doctors with calls asking when a shot would be available.

"It's made a lot of headlines in the U.S.," said Althoff. "Every contract takes into account that you're making a commitment with many unknown variants, and one of the variants was the yield, which then delays the amount of available at one given time."

In fact, the amount of seed virus Novartis was able to produce was initially far below expectations, though the yield has since been increased, said Althoff.

"The (U.S.) government has always been updated on this progress," he said.

shares were down 0.9 percent at 52.85 Swiss francs ($51.53) on the Zurich exchange Thursday.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Evidence lacking for long-term opioid use in low back pain

add to favorites email to friend print save as pdf

Related Stories

Novartis starts testing swine flu vaccine

Aug 05, 2009

(AP) -- Swiss drugmaker Novartis has begun injecting its swine flu vaccine into people in the company's first human tests, a spokesman said Wednesday. The vaccine is being tested in a yearlong trial of 6,000 ...

Novartis denies problems with swine flu vaccine

Oct 26, 2009

Swiss pharmaceutical group Novartis on Monday denied that it faced hurdles in gaining regulatory approval in Switzerland for one of its swine flu vaccines because of possible bacterial contamination.

Glaxo offers WHO 50 million pandemic vaccines

May 19, 2009

(AP) -- Drug giant GlaxoSmithKline said it has offered to donate 50 million doses of a pandemic vaccine to the World Health Organization in the event of a global flu outbreak, according to a company spokesman.

Sanofi to deliver swine flu vaccine in October

Sep 21, 2009

(AP) -- Sanofi-Aventis SA will begin delivering the first doses of its new swine flu vaccine in the United States by mid-October, the head of France's largest pharmaceutical company said Monday.

FDA approves new swine flu vaccine

Sep 15, 2009

(AP) -- The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month. Health and Human Services Secretary ...

Recommended for you

Pyridoxine-doxylamine drug safety data lacking

14 hours ago

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

FDA approves new type 2 diabetes drug

Apr 15, 2014

(HealthDay)—Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

Progress in the fight against quantum dissipation

(Phys.org) —Scientists at Yale have confirmed a 50-year-old, previously untested theoretical prediction in physics and improved the energy storage time of a quantum switch by several orders of magnitude. ...

Meteorites yield clues to Martian early atmosphere

(Phys.org) —Geologists who analyzed 40 meteorites that fell to Earth from Mars unlocked secrets of the Martian atmosphere hidden in the chemical signatures of these ancient rocks. Their study, published ...